Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 2/20 | 0.70 |
| ▸ | JUN | P05412 | 1/20 | 0.70 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.70 |
| ▸ | CA1 | P00915 | 1/20 | 0.68 |
| ▸ | CA2 | P00918 | 1/20 | 0.68 |
| ▸ | CA4 | P22748 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | BCHE | P06276 | 1/20 | 0.61 |
| ▸ | GUSB | P08236 | 1/20 | 0.61 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.54 |
| ▸ | CDK4 | P11802 | 1/20 | 0.53 |
| ▸ | CCND1 | P24385 | 1/20 | 0.53 |
| ▸ | ALPL | P05186 | 1/20 | 0.53 |
| ▸ | ALPI | P09923 | 1/20 | 0.53 |
| ▸ | ALPG | P10696 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8687395 | 1.00 | NFKB1 (0.70) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL29625452 | 1.00 | NFKB1 (0.70) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL765999 | 1.00 | NFKB1 (0.70) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL766000 | 1.00 | NFKB1 (0.70) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL11406934 | 0.98 | NFKB1 (0.68) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL2328371 | 0.87 | NFKB1 (0.50) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL5465666 | 0.84 | IAPP (0.68) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL1160535 | 0.83 | NFKB1 (1.00) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL29539991 | 0.83 | NFKB1 (1.00) | NFKB1JUNNFE2L2CA1CA2 | |
| SCHEMBL1160537 | 0.83 | NFKB1 (1.00) | NFKB1JUNNFE2L2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113402491-A | Coumarin amide compound and preparation method and application thereof | 山东大学苏州研究院 | 2021-09-17 | — | — | CN | claimed |
| CN-107935976-B | Coumarin amide derivative and application thereof | 山东大学 | 2020-01-17 | — | — | CN | claimed |
| EP-4737505-A1 | RESIN, PHOTOSENSITIVE COMPOSITIONS, CURED OBJECT, DISPLAY DEVICE, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED OBJECT | Toray Industries, Inc. (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20260079397-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | TORAY INDUSTRIES, INC. (JP) | 2026-03-19 | — | — | US | disclosed |
| CN-117362259-B | 6-Azo phenyl coumarin-3-formamide compound, and preparation method and application thereof | 南京林业大学 | 2025-08-08 | — | — | CN | disclosed |
| EP-4597224-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | Toray Industries, Inc. (JP) | 2025-08-06 | — | — | EP | disclosed |
| CN-120078865-A | Medicinal tea composition, medicinal tea liquid and application thereof | 新疆和田学院 | 2025-06-03 | — | — | CN | disclosed |
| CN-119895333-A | Photosensitive composition, cured product, electronic component, and method for producing cured product | 东丽株式会社 | 2025-04-25 | — | — | CN | disclosed |
| CN-117777114-A | Large Stokes displacement near-infrared cell membrane targeting dye based on coumarin skeleton and preparation method and application thereof | 西藏自治区人民政府驻成都办事处医院 | 2024-03-29 | — | — | CN | disclosed |
| CN-117362259-A | 6-azo phenyl coumarin-3-formamide compound, and preparation method and application thereof | 南京林业大学 | 2024-01-09 | — | — | CN | disclosed |
| CN-116947796-A | Method for synthesizing coumarin-3-carboxylic ester | 常州大学 | 2023-10-27 | — | — | CN | disclosed |
| WO-2006050501-A2 | NOVOBIOCIN ANALOGUES AS ANTICANCER AGENTS | UNIVERSITY OF KANSAS (US) | 2006-05-11 | — | — | WO | disclosed |
| US-6852310-B2 | Skin lightening agents, compositions and methods | UNILEVER HOME & PERSONAL CARE USA DIVISION OF CONOPCO, INC. (US) | 2005-02-08 | — | — | US | disclosed |
| CN-1506359-A | Coumarin amide derivative and its prepn, medicinal composition and use | �й�ҽѧ��ѧԺҩ���о��� | 2004-06-23 | — | — | CN | disclosed |
| WO-2004017936-A1 | SKIN LIGHTENING AGENTS COMPRISING COUMARIN DERIVED FROM RESORCINOL DERIVATIVES | UNILEVER PLC (GB) | 2004-03-04 | — | — | WO | disclosed |
| US-20040042983-A1 | Skin lightening agents, compositions and methods | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2004-03-04 | — | — | US | disclosed |
| EP-0869785-B1 | 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS | UPJOHN CO (US) | 2002-08-28 | — | — | EP | disclosed |
| EP-0869785-A1 | 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF DIABETES MELLITUS | PHARMACIA & UPJOHN COMPANY (US) | 1998-10-14 | — | — | EP | disclosed |
| US-5723476-A | 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus | PHARMACIA & UPJOHN COMPANY (US) | 1998-03-03 | — | — | US | disclosed |
| WO-1997018808-A1 | 4-HYDROXYCOUMARIN-3-CARBOXAMIDES FOR THE TREATMENT OF DIABETES MELLITUS | PHARMACIA & UPJOHN COMPANY (US) | 1997-05-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260079397-A1 | PHOTOSENSITIVE COMPOSITION, CURED PRODUCT, ELECTRONIC COMPONENT, AND METHOD FOR PRODUCING CURED PRODUCT | PPA1, PHOSPHO1, PHPT1 | NFKB1 3988/4885JUN 4762/4885NFE2L2 2912/4885 |
| US-20040042983-A1 | Skin lightening agents, compositions and methods | AOC3, TYR, CYP8B1 | NFKB1 3030/4885JUN 2469/4885NFE2L2 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.